The Scientist

» cancer drugs

Most Recent

image: Infographic: Cancer Drug Pairings

Infographic: Cancer Drug Pairings

By Anna Azvolinsky | April 1, 2018

Researchers use several different strategies to deliver a one-two punch.

0 Comments

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By Bob Grant | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.

0 Comments

image: Lavish Spending at MD Anderson

Lavish Spending at MD Anderson

By Kate Yandell | May 28, 2013

The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By Dan Cossins | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: $18M Grant to Be Re-reviewed

$18M Grant to Be Re-reviewed

By Jef Akst | June 1, 2012

A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.

5 Comments

image: Collecting Cancer Data

Collecting Cancer Data

By Hannah Waters | March 29, 2012

Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.

0 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Prevalent Form of Childhood Leukemia May Be Preventable
  4. Conservation Biologist Ben Collen Dies of Bone Cancer